The UK bodies responsible for regulatory and ethics review of clinical trials are being urged to issue clearer guidance on supporting decentralized clinical trials (DCTs) to give study sponsors more confidence in conducting them.
Undertaking Decentralized Clinical Trials In The UK ‘Should Not Be A Luxury’
UK needs to do more to address the current uncertainty among sponsors on how decentralized clinical trials can generate regulatory-grade data.
